TIEG1 is upregulated in Lrp5/6-mediated valve osteogenesis

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Biochemistry

Background:

• Lrp5/6/β-catenin signaling is crucial in valve calcification and osteogenic phenotypes.
• TIEG1 is implicated in Wnt signaling and osteoblast differentiation in bone.
• Hypercholesterolemia is a risk factor for cardiovascular disease, including valve calcification.

Purpose of the Study:

• To investigate the role of TIEG1 in mediating Wnt signaling in hypercholesterolemic valve disease.
• To explore the mechanism by which TIEG1 influences valve osteogenesis.

Main Methods:

• Utilized a mouse model of hypercholesterolemic valve disease (Lrp5-/-/ApoE-/- mice).
• Administered cholesterol diets with and without atorvastatin.
• Performed real-time polymerase chain reaction for gene expression analysis (TIEG1, Lrp6, Runx2).
• Conducted in vitro coexpression assays with valvular interstitial cells (VICs) and TOPFLASH reporter.

Main Results:

• Upregulation of TIEG1 and Runx2 gene expression observed in hypercholesterolemic valves.
• Mild increase in Lrp6 expression noted.
• TIEG1 and β-catenin co-localization within VIC nuclei confirmed after TGF-β stimulation.
• Coactivation of TOPFLASH reporter by β-catenin, TIEG1, and LEF1 in vitro.

Conclusions:

• TIEG1 plays a significant role in mediating Wnt signaling-induced valve osteogenesis.
• TIEG1 is a key mediator in the development of calcific aortic valve disease.
• Targeting TIEG1 may offer a therapeutic strategy for valve calcification.